DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 05 · Volume 47 · July 2021 DOI: 10.1055/s-011-51252 Altered Fibrinolysis: Clinical Impact and Diagnostic Challenges Guest Editors: Anne-Mette Hvas, MD, PhD, Julie Brogaard Larsen, MD, PhD, and Ton Lisman, MSc, PhD

Editorial

Preface

477
Larsen, Julie Brogaard; Lisman, Ton; Hvas, Anne-Mette: Preface: Altered Fibrinolysis—Clinical Impact and Diagnostic Challenges

Review Article

490
Kietsiriroje, Noppadol; Ariëns, Robert A.S.; Ajjan, Ramzi A.: Fibrinolysis in Acute and Chronic Cardiovascular Disease
506
512
Colomina, Maria J.; Méndez, Esther; Sabate, Antoni: Altered Fibrinolysis during and after Surgery
520
Roberts, Ian; Brenner, Amy; Shakur-Still, Haleema: Tranexamic Acid Treatment for Trauma Victims
538
Hovgesen, Nadia Thrane; Larsen, Julie Brogaard; Fenger-Eriksen, Christian; Hansen, Anne Kirkeby; Hvas, Anne-Mette: Efficacy and Safety of Antifibrinolytic Drugs in Pediatric Surgery: A Systematic Review
569
Bønløkke, Søren Thorgaard; Ommen, Hans Beier; Hvas, Anne-Mette: Altered Fibrinolysis in Hematological Malignances
581
Winther-Larsen, Anne; Sandfeld-Paulsen, Birgitte; Hvas, Anne-Mette: Hyperfibrinolysis in Patients with Solid Malignant Neoplasms: A Systematic Review
601
von Meijenfeldt, Fien A.; Lisman, Ton: Fibrinolysis in Patients with Liver Disease